'Ignore the noise and add value': Biome Australia on a roll with Priceline distribution deal
Microbiome health company Biome Australia (ASX: BIO) has signed a deal with Priceline Pharmacy Group to sell its core range of activated probiotics across 370 pharmacies, taking its distribution footprint to roughly 3,000 stores across Australia.
The agreement represents a 50 per cent boost to Biome's distribution network since listing last November as it looks to grow its presence in a probiotics market that is estimated to be worth $450 million.
Priceline, which is backed by both API and its new owner Wesfarmers group (ASX: WES), will initially place an allocation in its stores in June and July to tie in with its launch of the inaugural health masterclass education series.
Comments
Post a Comment